Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracoronary tenecteplase versus manual thrombectomy during PCI for STEMI
2014-005369-64Phase 3Active
- Sponsor
- Parc de Salut Mar
- Start
- Mar 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tenecteplase in acute ST-segment elevation myocardial infarction (STEMI) (2 arms), sponsored by Parc de Salut Mar. Primary endpoint: Necrotic myocardial volume. Started Mar 2015; status: active.
02
Drugs
tenecteplase
03
Conditions
acute ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on 2014-005369-64.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005369-64.